Scientific article

BARD1, a possible biomarker for breast and ovarian cancer

ContributorsIrminger, Irmgard
Published inGynecologic oncology, vol. 117, no. 2, p. 211-215
Publication date2010

Breast cancer is the leading cause of cancer death in women. Ovarian cancer, although less frequent, is detected very late, and survival is correlated to early detection. Therefore, better methods for early detection would help to increase the number of survivors. The incidence of young women diagnosed with breast cancer is increasing. These women and women who are at risk because of a family history of breast cancer would benefit from more accurate and less invasive screening methods than those in place today. A blood test based on BARD1, a protein that interacts with the breast cancer gene product BRCA1, is a promising candidate for fulfilling these conditions. The science behind BARD1 and its role in breast and ovarian cancer is explained in this article.

  • Breast Neoplasms/blood/genetics
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Ovarian Neoplasms/blood/genetics
  • Tumor Markers, Biological/blood/genetics
  • Tumor Suppressor Proteins/blood/genetics
  • Ubiquitin-Protein Ligases/blood/genetics
Citation (ISO format)
IRMINGER, Irmgard. BARD1, a possible biomarker for breast and ovarian cancer. In: Gynecologic oncology, 2010, vol. 117, n° 2, p. 211–215. doi: 10.1016/j.ygyno.2009.10.079
Main files (1)
Article (Published version)
ISSN of the journal0090-8258

Technical informations

Creation05/25/2012 10:52:00 AM
First validation05/25/2012 10:52:00 AM
Update time03/14/2023 5:36:43 PM
Status update03/14/2023 5:36:43 PM
Last indexation01/15/2024 11:56:04 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack